They ran four parallel studies based on different patient profiles: ADM trial: Patients with type 2 diabetes (T2D), comparing newer GLP-1 RAs to older GLP-1 RAs, sulfonylureas, and other anti-diabetic medications (ADMs)
One patient I spoke to had been using compounded GLP-1s to manage her lupus symptoms because of cost issues and was increasing her dose without consulting her doctor whenever she felt its effects plateau
Heart disease, liver disease, medication effects, infection, and other kidney conditions can cause similar problems
10.1007/s10689-014-9757-9 67 ZhangY.XiX.MeiY.ZhaoX.ZhouL.MaM.et al (2019)
In patients with elevated inflammation markers, exendin-4 reduced key biomarkers such as levels of proinflammatory cytokines TNF- and Il-1, toll-like receptors TLR2 and TLR4, JNK-1, and others [167]
Tirzepatide Dual-Action Weight Management Tirzepatide is the active ingredient in FDA-approved dual GLP-1/GIP receptor agonist medications
